Retweet Rank: 397,175 - approx 95.23 percentile

434
TWEETS
437
FOLLOWERS
401
FOLLOWING

Web: http://t.co/7HXHHOQZO8
Bio: Developing therapies that offer exquisite selectivity for the toxic oligomer, a root cause of Alzheimer’s, Parkinson’s and ALS

Get the most advanced stats for twitter

Track your retweets, engagement, monitor your brand, download retweets and do much more with Retweet Rank.

Sign in with twitter

Recent Retweets | Top Retweets | Download Retweets | Dashboard

RT @ProMISinc: ProMIS Neurosciences Adds Pharmaceutical Leader Timothy Rothwell to Board of Advisors https://t.co/qeK3f8zO3i
RT @ProMISinc: ProMIS discovers potential Parkinson’s antibody therapies with best-in-class selectivity for toxic forms of alpha-s… https://t.co/hGxTR7U2ok
RT @ProMISinc: New antibody candidates for Parkinson’s show how ProMIS’ new drug discovery and development platform can create dru… https://t.co/P1LkWGGW1t
RT @ProMISinc: Could Roche’s Alzheimer’s drug failure be Promis Neurosciences gain? https://t.co/FSABjmZsXs #crenezumab failure i… https://t.co/ZtZnD2AvXT
RT @ProMISinc: New antibody candidates for Parkinson’s show how ProMIS’ new drug discovery and development platform can create dru… https://t.co/P1LkWGGW1t
RT @ProMISinc: New antibody candidates for Parkinson’s show how ProMIS’ new drug discovery and development platform can create dru… https://t.co/P1LkWGGW1t
RT @ProMISinc: New antibody candidates for Parkinson’s show how ProMIS’ new drug discovery and development platform can create dru… https://t.co/P1LkWGGW1t
RT @ProMISinc: ProMIS discovers potential Parkinson’s antibody therapies with best-in-class selectivity for toxic forms of alpha-s… https://t.co/hGxTR7U2ok
RT @ProMISinc: ProMIS discovers potential Parkinson’s antibody therapies with best-in-class selectivity for toxic forms of alpha-s… https://t.co/hGxTR7U2ok
RT @ProMISinc: Could Roche’s Alzheimer’s drug failure be Promis Neurosciences gain? https://t.co/FSABjmZsXs #crenezumab failure i… https://t.co/ZtZnD2AvXT

You might like to see retweet rank of

  • Paul Newhouse, M.D.
  • BNN Bloomberg
  • Eden
  • Ron Leuty
  • Murad Hemmadi
  • Jean Georges
  • Life Sciences Report
  • AD/PD
  • Alzforum
  • The Logic
  • Mass General Research
  • When Life Gives You Parkinson's
  • Derek Lowe
  • Ben Hargreaves
  • Canada's Markets
  • Cantech Letter
  • Canadian Business
  • BioPharma-Reporter
  • Larry Gifford
  • EPDA

Try Retweet Rank premium insights for FREE

Sign Up Now